Lotilaner Ophthalmic Solution, 0.25%, for the Treatment of Demodex Blepharitis: Results of a Prospective, Randomized, Vehicle-Controlled, Double-Masked, Pivotal Trial (Saturn-1)

por Yeu, Elizabeth, Wirta, David L., Karpecki, Paul, Baba, Stephanie N., Holdbrook, Mark
Publicado 2023

A nonrandomized, open-label study to evaluate the effect of nasal stimulation on tear production in subjects with dry eye disease

por Friedman, Neil J, Butron, Karla, Robledo, Nora, Loudin, James, Baba, Stephanie N, Chayet, Arturo
Publicado 2016

Psychosocial Impact of Demodex Blepharitis

por O’Dell, Leslie, Dierker, Damon S, Devries, Douglas K, Garlich, Jaclyn, Whitley, Walter O, Holdbrook, Mark, Baba, Stephanie N, Yeu, Elizabeth
Publicado 2022

Safety and Efficacy of Topical Lotilaner Ophthalmic Solution 0.25% for the Treatment of Demodex Blepharitis: A Pilot Study

por Gonzalez-Salinas, Roberto, Yeu, Elizabeth, Holdbrook, Mark, Baba, Stephanie N., Ceballos, Juan Carlos, Massaro-Corredor, Martha, Corredor-Ortega, Claudia, Ramos-Betancourt, Nallely, Quiroz-Mercado, Hugo
Publicado 2021